Stay updated on ERICA Clinical Trial
Sign up to get notified when there's something new on the ERICA Clinical Trial page.

Latest updates to the ERICA Clinical Trial page
- Check3 days agoChange DetectedThe page now displays the study record for the ESK981 and nivolumab trial in metastatic renal cell carcinoma, including its termination after eight participants enrolled and the fact that no participants entered Cohort B. It also provides the trial’s eligibility criteria, treatment plan, measured outcomes, and study documents.SummaryDifference52%

- Check10 days agoChange DetectedThe site revision changed from v3.7.2 to v3.8.0, while the study record remains inaccessible.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA site-wide NIH notice was added about a website transition and the use of “Super Intelligence” in place of “Artificial Intelligence.” The site revision marker changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe site revision marker in the error-page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now displays a 403 Forbidden error instead of loading the study record. This indicates a permissions issue or access restriction to the requested ClinicalTrials.gov entry rather than a change in the study data.SummaryDifference19%

- Check59 days agoChange DetectedThe page revision has been updated from v3.6.6 to v3.7.0. This indicates a newer release of the page content.SummaryDifference0.1%

Stay in the know with updates to ERICA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ERICA Clinical Trial page.